Novel GIGYF2 gene variants in patients with Parkinson's disease in Chinese population

Neuroscience Letters

Volumn 473, Issue 2, 2010, Pages 131-135

  Wang, Lei ^a   Guo, Ji feng ^a,c   Zhang, Wen wen ^a   Xu, Qian ^a   Zuo, Xing ^a   Shi, Chang he ^a   Luo, Lin zi ^a   Liu, Jia ^a   Hu, Liang ^a   Hu, Ya cen ^a   She, Lu ^a,c   Jiang, Hong ^a,c   Yan, Xin xiang ^a,c   Xia, Kun ^b   Pan, Qian ^b   Tang Bei sha, B S ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b State Key Laboratory of Medical Genetics of China   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

GIGYF2 gene; Parkinson's disease; Variants

Indexed keywords

COMPLEMENTARY DNA; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10 INTERACTING GYF PROTEIN 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 77949912959     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.037     Document Type: Article

References (36)

1. Bonetti M., Ferraris A., Petracca M., Bentivoglio A.R., Dallapiccola B., Valente E.M. GIGYF2 variants are not associated with Parkinson's disease in Italy. Mov. Disord. 2009, 15:1867-1868.
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
3. Bras J., Simon-Sanchez J., Federoff M., Morgadinho A., Januario C., Ribeiro M., Cunha L., Oliveira C., Singleton A.B. Lack of replication of association between GIGYF2 variants and Parkinson disease. Hum. Mol. Genet. 2009, 18:341-346.
4. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
5. Di Fonzo A., Dekker M.C., Montagna P., Baruzzi A., Yonova E.H., Correia Guedes L., Szczerbinska A., Zhao T., Dubbel-Hulsman L.O., Wouters C.H., de Graaff E., Oyen W.J., Simons E.J., Breedveld G.J., Oostra B.A., Horstink M.W., Bonifati V. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 2009, 72:240-245.
6. Di Fonzo A., Fabrizio E., Thomas A., Fincati E., Marconi R., Tinazzi M., Breedveld G.J., Simons E.J., Chien H.F., Ferreira J.J., Horstink M.W., Abbruzzese G., Borroni B., Cossu G., Dalla Libera A., Fabbrini G., Guidi M., De Mari M., Lopiano L., Martignoni E., Marini P., Onofrj M., Padovani A., Stocchi F., Toni V., Sampaio C., Barbosa E.R., Meco G. GIGYF2 mutations are not a frequent cause of familial Parkinson's disease. Parkinsonism. Relat. Disord. 2009, 15:703-705. Italian Parkinson Genetics Network, B.A. Oostra, V. Bonifati.
7. Dufresne A.M., Smith R.J. The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling. Endocrinology 2005, 146:4399-4409.
8. Giovannone B., Lee E., Laviola L., Giorgino F., Cleveland K.A., Smith R.J. Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J. Biol. Chem. 2003, 278:31564-31573.
9. Giovannone B., Tsiaras W.G., de la Monte S., Klysik J., Lautier C., Karashchuk G., Goldwurm S., Smith R.J. GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling. Hum. Mol. Genet. 2009, 18:4629-4639.
10. Healy D.G., Abou-Sleiman P.M., Casas J.P., Ahmadi K.R., Lynch T., Gandhi S., Muqit M.M., Foltynie T., Barker R., Bhatia K.P., Quinn N.P., Lees A.J., Gibson J.M., Holton J.L., Revesz T., Goldstein D.B., Wood N.W. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 2006, 59:627-633.
11. Holt L.J., Siddle K. Grb10 and Grb14: enigmatic regulators of insulin action and more?. J. Biochem. 2005, 388:393-406.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
13. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
14. Langlais P., Dong L.Q., Ramos F.J., Hu D., Li Y., Quon M.J., Liu F. Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10. Mol. Endocrinol. 2004, 18:350-358.
15. Lautier C., Goldwurm S., Durr A., Giovannone B., Tsiaras W.G., Pezzoli G., Brice A., Smith R.J. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am. J. Hum. Genet. 2008, 82:822-833.
16. Laviola L., Giorgino F., Chow J.C., Baquero J.A., Hansen H., Ooi J., Zhu J., Riedel H., Smith R.J. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. J. Clin. Invest. 1997, 99:830-837.
17. Lesage S., Condroyer C., Lohman E., Troiano A., Tison F., Viallet F., Damier P., Tranchant C., Vidhaillet M., Ouvrard-Hernandez A.M., Durr A., Brice A. Follow-up study of the GIGYF2 gene in French families with Parkinson's disease. Neurobiol. Aging 2009, for the French Parkinson's Disease Genetics Study Group (FPDGSG), (Epub ahead of print).
18. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., Ballinger D.G. High-resolution whole-genome association study of Parkinson's disease. Am. J. Hum. Genet. 2005, 77:685-693.
19. Meeus B., Nuytemans K., Crosiers D., Meeus B., Nuytemans K., Crosiers D., Engelborghs S., Pals P., Pickut B., Peeters K., Mattheijssens M., Corsmit E., Cras P., De Deyn P.P., Theuns J., Van Broeckhoven C. GIGYF2 has no major role in parkinson genetic etiology in a Belgian population. Neurobiol. Aging 2009, (Epub ahead of print).
20. Mori K., Giovannone B., Smith R.J. Distinct Grb10 domain requirements for effects on glucose uptake and insulin signaling. Mol. Cell. Endocrinol. 2005, 230:39-50.
21. Nichols W.C., Kissell D.K., Pankratz N., Nichols W.C., Kissell D.K., Pankratz N., Pauciulo M.W., Elsaesser V.E., Clark K.A., Halter C.A., Rudolph A., Wojcieszek J., Pfeiffer R.F., Foroud T. Variation in GIGYF2 is not associated with Parkinson disease. Neurology 2009, 72:1886-1892. Parkinson Study Group-PROGENI Investigators.
22. Paisan-Ruiz C., Bhatia K.P., Li A., Hernandez D., Davis M., Wood N.W., Hardy J., Houlden H., Singleton A., Schneider S.A. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann. Neurol. 2009, 65:19-23.
23. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
24. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet. 2002, 71:124-135. Parkinson Study Group.
25. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Significant linkage of Parkinson disease to chromosome 2q36-37. Am. J. Hum. Genet. 2003, 72:1053-1057. Parkinson Study Group.
26. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Murrell J., Rudolph A., Shults C.W., Conneally P.M., Foroud T. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum. Mol. Genet. 2003, 12:2599-2608. Parkinson Study Group.
27. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
28. Prestel J., Sharma M., Leitner P., Zimprich A., Vaughan J.R., Durr A., Bonifati V., De Michele G., Hanagasi H.A., Farrer M., Hofer A., Asmus F., Volpe G., Meco G., Brice A., Wood N.W., Muller-Myhsok B., Gasser T. PARK11 is not linked with Parkinson's disease in European families. Eur. J. Hum. Genet. 2005, 13:193-197. European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD).
29. Ramirez A., Heimbach A., Gründemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 2006, 38:1184-1191.
30. Samaranch L., Lorenzo E., Pastor M.A., Riverol M., Luquin M.R., Rodriguez-Oroz M.C., Obeso J.A., Pastor P. Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population. Eur. J. Neurol. 2009, (Epub ahead of print).
31. Samii A., Nutt J.G., Ransom B.R. Parkinson's disease. Lancet 2004, 363:1783-1793.
32. Simon-Sanchez J., Singleton A.B. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum. Mol. Genet. 2008, 17:1988-1993.
33. Sutherland G.T., Siebert G.A., Newman J.R., Silburn P.A., Boyle R.S., Sullivan J.D.O., Mellick G.D. Haplotype analysis of the PARK11 gene, GIGYF2, in sporadic Parkinson's disease. Mov. Disord. 2009, 24:449-452.
34. Tan E.K., Lin C.H., Tai C.H., Tan L.C., Chen M.L., Li R., Lim H.Q., Pavanni R., Yuen Y., Prakash K.M., Zhao Y., Wu R.M. Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations. Hum. Genet. 2009, 126:425-430.
35. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
36. Vilarino-Guell C., Ross O.A., Soto A.I., Farrer M.J., Haugarvoll K., Aasly J.O., Uitti R.J., Wszolek Z.K. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov. Disord. 2009, 24:619-620.